Skip to main content

Euthyrox Side Effects

Generic name: levothyroxine

Medically reviewed by Drugs.com. Last updated on Mar 11, 2024.

Note: This document provides detailed information about Euthyrox Side Effects associated with levothyroxine. Some dosage forms listed on this page may not apply specifically to the brand name Euthyrox.

Applies to levothyroxine: injection powder for solution.

Other dosage forms:

Serious side effects of Euthyrox

Along with its needed effects, levothyroxine (the active ingredient contained in Euthyrox) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking levothyroxine:

Rare

  • seizures

Incidence not known

  • fast heartbeat
  • fever
  • hives, itching, skin rash
  • hoarseness
  • irritation
  • joint pain, stiffness, or swelling
  • redness of the skin
  • swelling of the eyelids, face, lips, hands, or feet
  • tightness in the chest
  • troubled breathing or swallowing

Get emergency help immediately if any of the following symptoms of overdose occur while taking levothyroxine:

For healthcare professionals

Applies to levothyroxine: compounding powder, injectable powder for injection, intravenous powder for injection, intravenous solution, oral capsule, oral solution, oral tablet.

General

The more commonly reported adverse events have included those of hyperthyroidism due to therapeutic overdose including arrhythmias, myocardial infarction, dyspnea, muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite, weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash.

Cardiovascular

Cardiac function was evaluated in 20 patients requiring TSH suppression for either thyroid goiter or following thyroidectomy and radioactive iodine therapy for thyroid cancer and in 20 age and sex-matched controls. TSH suppression was associated with an increased incidence of premature ventricular beats, an increased left ventricular mass index, and enhanced left ventricular systolic function. The clinical significance of these changes remains to be determined.

Overtreatment with this drug may cause an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias, particularly in patients with cardiovascular disease and in elderly patients.[Ref]

Endocrine

Nervous system

Dermatologic

Musculoskeletal

A study evaluated the effect of long-term thyroid hormone therapy on bone mineral density in 196 women (mean age, 74.4 years) compared to a control group comprised of 795 women (mean age, 72.1 years). The mean daily thyroxine dose was 1.99 mcg/kg (range, 0.3 to 6.6 mcg/kg) with a mean duration of therapy of 20.4 years (range, less than 1 to 68 years). Women taking daily doses of 1.6 mcg/kg or more had significantly lower bone mineral density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared to controls. However, estrogen use appeared to negate the adverse effects of thyroid hormone on bone mineral density.

Higher rates of femur fractures have been found in males (p=0.008) prescribed long-term thyroid hormone therapy as compared to controls in a case-control analysis of 23,183 patients, from the United Kingdom General Practice Research Database, prescribed thyroid hormone.

Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height.[Ref]

Gastrointestinal

Genitourinary

Hypersensitivity

Hypersensitivity reactions have occurred; however, it has been attributed to the inactive ingredients. These reactions have included urticaria, pruritus, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur.[Ref]

Metabolic

Immunologic

Other

Psychiatric

References

1. Petersen K, Bengtason C, Lapidus L, et al. (1990) "Morbidity, mortality, and quality of life for patients treated with levothyroxine." Arch Intern Med, 150, p. 2077-81

2. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC (1992) "Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH." Clin Endocrinol (Oxf), 37, p. 500-3

3. (2002) "Product Information. Synthroid (levothyroxine)." Abbott Pharmaceutical

4. Sheppard MC, Holder R, Franklyn JA (2002) "Levothyroxine treatment and occurrence of fracture of the hip." Arch Intern Med, 162, p. 338-43

5. Cerner Multum, Inc. "UK Summary of Product Characteristics."

6. Pharmaceutical Society of Australia (2006) APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp

Frequently asked questions

Further information

Euthyrox side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.